Madine, M., Chennuri, R. N., Prathipati, R., Shah, V., Maroules, M. (2026). Real-world eligibility for perioperative pembrolizumab in resectable locally advanced head and neck squamous cell carcinoma: A SEER-based analysis following KEYNOTE-689.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e18059